Evidence map›Paper›PMID 24700756›Full record

ArticleThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society2014

Characterization of Leukocyte Formin FMNL1 Expression in Human Tissues.

Maria Gardberg, Vanina D Heuser, Kristiina Iljin, Caroline Kampf, Mathias Uhlen, Olli Carpén

Open access · bronzeAbstract read
In one paragraph

Article in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Heliyon · 2022
    Article
  10. Article
  11. Role of formin INF2 in human diseases.Molecular biology reports · 2022
    Review
  12. FHOD1 and FMNL1 formin proteins in intestinal gastric cancer: correlation with tumor-infiltrating T lymphocytes and molecular subtypes.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2021
    Article
  13. Article
  14. FMNL1 Exhibits Pro-Metastatic ActivityFrontiers in oncology · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Maria GardbergDepartment of Pathology, University of Turku and Turku University Hospital, Turku, Finland (MG,VDH, OC)Medical Biotechnology, VTT Technical Research Centre of Finland, and Turku Centre for Biotechnology, University of Turku, Turku, Finland (KI)Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden (CK)Science for Life Laboratory and Albanova University Center Royal Institute of Technology, Stockholm, Sweden (MU) magard@utu.fi.
Vanina D HeuserDepartment of Pathology, University of Turku and Turku University Hospital, Turku, Finland (MG,VDH, OC)Medical Biotechnology, VTT Technical Research Centre of Finland, and Turku Centre for Biotechnology, University of Turku, Turku, Finland (KI)Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden (CK)Science for Life Laboratory and Albanova University Center Royal Institute of Technology, Stockholm, Sweden (MU).
Kristiina IljinDepartment of Pathology, University of Turku and Turku University Hospital, Turku, Finland (MG,VDH, OC)Medical Biotechnology, VTT Technical Research Centre of Finland, and Turku Centre for Biotechnology, University of Turku, Turku, Finland (KI)Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden (CK)Science for Life Laboratory and Albanova University Center Royal Institute of Technology, Stockholm, Sweden (MU).
Caroline KampfDepartment of Pathology, University of Turku and Turku University Hospital, Turku, Finland (MG,VDH, OC)Medical Biotechnology, VTT Technical Research Centre of Finland, and Turku Centre for Biotechnology, University of Turku, Turku, Finland (KI)Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden (CK)Science for Life Laboratory and Albanova University Center Royal Institute of Technology, Stockholm, Sweden (MU).
Mathias UhlenDepartment of Pathology, University of Turku and Turku University Hospital, Turku, Finland (MG,VDH, OC)Medical Biotechnology, VTT Technical Research Centre of Finland, and Turku Centre for Biotechnology, University of Turku, Turku, Finland (KI)Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden (CK)Science for Life Laboratory and Albanova University Center Royal Institute of Technology, Stockholm, Sweden (MU).
Olli CarpénDepartment of Pathology, University of Turku and Turku University Hospital, Turku, Finland (MG,VDH, OC)Medical Biotechnology, VTT Technical Research Centre of Finland, and Turku Centre for Biotechnology, University of Turku, Turku, Finland (KI)Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden (CK)Science for Life Laboratory and Albanova University Center Royal Institute of Technology, Stockholm, Sweden (MU).
Uppsala University · SEUniversity of Turku · FIKTH Royal Institute of Technology · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Formins are cytoskeleton regulating proteins characterized by a common FH2 structural domain. As key players in the assembly of actin filaments, formins direct dynamic cytoskeletal processes that influence cell shape, movement and adhesion. The large number of formin genes, fifteen in the human, suggests distinct tasks and expression patterns for individual family members, in addition to overlapping functions. Several formins have been associated with invasive cell properties in experimental models, linking them to cancer biology. One example is FMNL1, which is considered to be a leukocyte formin and is known to be overexpressed in lymphomas. Studies on FMNL1 and many other formins have been hampered by a lack of research tools, especially antibodies suitable for staining paraffin-embedded formalin-fixed tissues. Here we characterize, using bioinformatics tools and a validated antibody, the expression pattern of FMNL1 in human tissues and study its subcellular distribution. Our results indicate that FMNL1 expression is not restricted to hematopoietic tissues and that neoexpression of FMNL1 can be seen in epithelial cancer.

Indexed as

actin cytoskeletonFMNL1forminFRL1immunohistochemistry

Identifiers

PMID24700756
PMCPMC4174630
OpenAlexW2066323505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.